SPHK2 and acute lymphoblastic leukemia: Furthermore, blockage of SPHK1 and/or SPHK2 using different small molecule inhibitors, such as SKI-I, SKI-II, and ABC294640 resulted in synergistic cell death of Ph+ ALL cell lines when combined with imatinib.